Human papillomavirus genotyping and integration in ovarian cancer Saudi patients

Virology Journal

Volumn 10, Issue , 2013, Pages

  Al Shabanah, Othman A ^a   Hafez, Mohamed M ^a   Hassan, Zeinab K ^a   Sayed Ahmed, Mohamed M ^a   Abozeed, Waleed N ^b   Al Rejaie, Salem S ^a   Alsheikh, Abdulmalik A ^c  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b KING KHALID UNIVERSITY HOSPITAL   (Saudi Arabia)

^c KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

DNA sequencing; Formalin paraffin embedded tissue; Human papilloma virus; Ovarian cancer; Polymerase chain reaction

Indexed keywords

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER STAGING; COMPARATIVE STUDY; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; GENOME; GENOTYPE; HIGH RISK PATIENT; HOST; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 45; HUMAN PAPILLOMAVIRUS TYPE 6; HUMAN TISSUE; MAJOR CLINICAL STUDY; OVARY CARCINOMA; POLYMERASE CHAIN REACTION; SAUDI ARABIA; SEROPREVALENCE; WART VIRUS;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; PAPILLOMAVIRIDAE;

ADULT; AGED; DNA PRIMERS; FEMALE; GENOTYPE; HUMANS; MIDDLE AGED; OVARIAN NEOPLASMS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; PREVALENCE; SAUDI ARABIA; SEQUENCE ANALYSIS, DNA; VIRUS INTEGRATION;

EID: 84887736639     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-10-343     Document Type: Article

References (67)

1. Papillomavirus infections - a major cause of human cancers. zur Hausen H, Biochim Biophys Acta 1996 1288 2 55 78 8876633
2. Prevalence of cervical neoplastic lesions and human papilloma virus infection in egypt: national cervical cancer screening project. El-All HS, Refaat A, Dandash K, Infect Agent Cancer 2007 2 12 10.1186/1750-9378-2-12 17610742
3. Human papilloma virus (HPV) typing in preneoplastic and neoplastic lesions of the uterine cervix in the IX region-Chile. Melo A, Montenegro S, Hooper T, Capurro I, Roa JC, Roa I, Revista Med Chil 2003 131 12 1382 1390 (Pubitemid 40137736)
4. Detection of human papillomavirus-16 in ovarian malignancy. Wu QJ, Guo M, Lu ZM, Li T, Qiao HZ, Ke Y, Br J Cancer 2003 89 4 672 675 10.1038/sj.bjc. 6601172 12915876 (Pubitemid 37076171)
5. The causal relation between human papillomavirus and cervical cancer. Bosch FX, Lorincz A, Munoz N, Meijer CJ, Shah KV, J Clin Pathol 2002 55 4 244 265 10.1136/jcp.55.4.244 11919208 (Pubitemid 34293391)
6. There is a high prevalence of human papillomavirus infection in American Indian women of the northern plains. Bell MC, Schmidt-Grimminger D, Patrick S, Ryschon T, Linz L, Chauhan SC, Gynecol Oncol 2007 107 2 236 241 10.1016/j.ygyno.2007.06.007 17659767 (Pubitemid 47575718)
7. Seroprevalence of antibodies against human papillomavirus (HPV) types 16 and 18 in four continents: the international agency for research on cancer HPV prevalence surveys. Vaccarella S, Franceschi S, Clifford GM, Touze A, Hsu CC, de Sanjose S, Pham TH, Nguyen TH, Matos E, Shin HR, et al. Cancer Epidemiol Biomarkers Prev 2010 19 9 2379 2388 10.1158/1055-9965.EPI-10-0336 20826835
8. Detection and genotyping of human papilloma virus in cervical cancer specimens from Saudi patients. Al-Badawi IA, Al-Suwaine A, Al-Aker M, Asaad L, Alaidan A, Tulbah A, Fe Bohol M, Munkarah AR, Int J Gynecol Cancer 2011 21 5 907 910 10.1097/IGC.0b013e318214219f 21697680
9. High prevalence of human papillomavirus DNA detected in cervical swabs from women in southern Selangor, Malaysia. Chong PP, Asyikin N, Rusinahayati M, Halimatun S, Rozita R, Ng CK, Hamilton WH, Tan BC, Noraihan N, Rohani A, et al. Asian Pac J Cancer Prev 2010 11 6 1645 1651 21338211
10. Comparison of MY09/11 consensus PCR and type-specific PCRs in the detection of oncogenic HPV types. Depuydt CE, Boulet GA, Horvath CA, Benoy IH, Vereecken AJ, Bogers JJ, J Cell Mol Med 2007 11 4 881 891 10.1111/j.1582-4934. 2007.00073.x 17760847 (Pubitemid 47313308)
11. Detection of human papillomavirus (HPV) L1 gene DNA possibly bound to particulate aluminum adjuvant in the HPV vaccine gardasil. Lee SH, J Inorg Biochem 2012 117 85 92 23078778
12. Role of diaphragmatic surgery in 69 patients with ovarian carcinoma. Devolder K, Amant F, Neven P, van Gorp T, Leunen K, Vergote I, Int J Gynecol Cancer 2008 18 2 363 368 10.1111/j.1525-1438.2007.01006.x 18334014 (Pubitemid 351365206)
13. The scientific basis of early detection of epithelial ovarian cancer: the national ovarian cancer early detection program (NOCEDP). Fishman DA, Bozorgi K, Cancer Treat Res 2002 107 3 28 11775458
14. Ovarian carcinogenesis: an alternative hypothesis. Piek JM, van Diest PJ, Verheijen RH, Adv Exp Med Biol 2008 622 79 87 10.1007/978-0-387-68969-2-7 18546620
15. Cancer incidence and survival report Saudi Arabia. Al-Eid MSM HS, Shouki B, Ali A-Z, 2007 http://www.scr.org.sa/reports/SCR2007.pdf
16. Expression of cyclooxygenase-1 and 2 in chronic tonsillitis. Dilek FH, Sahin O, Tokyol C, Mazlum M, Aycicek A, Indian J Pathol Microbiol 2010 53 3 451 454 20699501
17. Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis. Shih Ie M, Kurman RJ, AmJ Pathol 2004 164 5 1511 1518 10.1016/S0002-9440(10)63708-X (Pubitemid 38529752)
18. Origins and molecular pathology of ovarian cancer. Bell DA, Mod Pathol 2005 18 2 19 32 15761464
19. Ovarian cancer and high-risk women-implications for prevention, screening, and early detection. Modugno F, Gynecol Oncol 2003 91 1 15 31 10.1016/S0090-8258(03)00254-3 14529658 (Pubitemid 37203405)
20. Detection of human papilloma virus DNA in seven cases of focal epithelial hyperplasia in Iran. Falaki F, Amir Chaghmaghi M, Pakfetrat A, Delavarian Z, Mozaffari PM, Pazooki N, J Oral Pathol Med 2009 38 10 773 776 10.1111/j.1600-0714.2009.00784.x 19453844
21. Simultaneous detection, genotyping, and quantification of human papillomaviruses by multicolor real-time PCR and melting curve analysis. Liao Y, Zhou Y, Guo Q, Xie X, Luo E, Li J, Li Q, J Clin Microbiol 2013 51 2 429 435 10.1128/JCM.02115-12 23175255
22. Protocol for the detection and genotyping of human papillomaviruses using a liquid bead microarray assay. Cherne S, Popov V, Feng Q, Methods Mol Biol 2012 903 205 223 10.1007/978-1-61779-937-2-13 22782820
23. Analytical and clinical performances of a restriction fragment mass polymorphism assay for detection and genotyping of a wide spectrum of human papillomaviruses. Lee HP, Kim SO, Hwang TS, Bae JM, Kim SN, Kim JW, Hwang SY, Lee HS, Shin SK, Cho W, et al. J Med Virol 2011 83 3 471 482 10.1002/jmv.21992 21264868
24. Detection of human papillomavirus DNA in malignant lesions from Chinese women with carcinomas of the upper genital tract. Ip SM, Wong LC, Xu CM, Cheung AN, Tsang PC, Ngan HY, Gynecol Oncol 2002 87 1 104 111 10.1006/gyno.2002.6784 12468350 (Pubitemid 36027109)
25. Secreted antagonists of the Wnt signalling pathway. Kawano Y, Kypta R, J Cell Sci 2003 116 Pt 13 2627 2634 12775774 (Pubitemid 36857216)
26. An epigenetic marker panel for screening and prognostic prediction of ovarian cancer. Su HY, Lai HC, Lin YW, Chou YC, Liu CY, Yu MH, Int J Cancer 2009 124 2 387 393 10.1002/ijc.23957 18942711
27. Human papillomavirus genotype distribution and human papillomavirus 16 and human papillomavirus 18 genomic integration in invasive and in situ cervical carcinoma in human immunodeficiency virus-infected women. Darwich L, Canadas MP, Sirera G, Alameda F, Forcada P, Delas J, Fernandez I, Llatjos M, Coll J, Clotet B, et al. Int J Gynecol Cancer 2011 21 8 1486 1490 10.1097/IGC. 0b013e31822a0195 21892092
28. Down-regulation of sfrp1 in a mammary epithelial cell line promotes the development of a cd44high/cd24low population which is invasive and resistant to anoikis. Gauger KJ, Hugh JM, Troester MA, Schneider SS, Cancer cell Int 2009 9 11 10.1186/1475-2867-9-11 19422694
29. Herpes simplex virus-2 as a human papillomavirus cofactor in the etiology of invasive cervical cancer. Smith JS, Herrero R, Bosetti C, Munoz N, Bosch FX, Eluf-Neto J, Castellsague X, Meijer CJ, Van den Brule AJ, Franceschi S, et al. J Natl Cancer Inst 2002 94 21 1604 1613 10.1093/jnci/94.21.1604 12419786 (Pubitemid 35378725)
30. Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case-control study. Munoz N, Franceschi S, Bosetti C, Moreno V, Herrero R, Smith JS, Shah KV, Meijer CJ, Bosch FX, Lancet 2002 359 9312 1093 1101 10.1016/S0140-6736(02)08151-5 11943256 (Pubitemid 34270732)
31. HPV16 E2 is an immediate early marker of viral infection, preceding E7 expression in precursor structures of cervical carcinoma. Xue Y, Bellanger S, Zhang W, Lim D, Low J, Lunny D, Thierry F, Cancer Res 2010 70 13 5316 5325 10.1158/0008-5472.CAN-09-3789 20530671
32. HPV genotyping and site of viral integration in cervical cancers in Indian women. Das P, Thomas A, Mahantshetty U, Shrivastava SK, Deodhar K, Mulherkar R, PloS one 2012 7 7 41012 10.1371/journal.pone.0041012 22815898
33. Papillomaviruses in the causation of human cancers-a brief historical account. zur Hausen H, Virology 2009 384 2 260 265 10.1016/j.virol.2008.11.046 19135222
34. HPV infections and oesophageal cancer. Syrjanen KJ, J Clin Pathol 2002 55 10 721 728 10.1136/jcp.55.10.721 12354793 (Pubitemid 35231898)
35. The role of human papilloma virus in lung cancer: a review of the evidence. Rezazadeh A, Laber DA, Ghim SJ, Jenson AB, Kloecker G, Am J Med Sci 2009 338 1 64 67 10.1097/MAJ.0b013e3181a393ba 19593105
36. Human papillomavirus type 18 in colorectal cancer. Lee YM, Leu SY, Chiang H, Fung CP, Liu WT, J Microbiol Immunol Infect 2001 34 2 87 91 11456365 (Pubitemid 32641337)
37. Evidence for an association of human papillomavirus and breast carcinomas. Damin AP, Karam R, Zettler CG, Caleffi M, Alexandre CO, Breast Cancer Res Treat 2004 84 2 131 137 10.1023/B:BREA.0000018411.89667.0d 14999143 (Pubitemid 38393363)
38. Detection of human papillomavirus DNA in advanced epithelial ovarian carcinoma. Kaufman RH, Bornstein J, Gordon AN, Adam E, Kaplan AL, Adler-Storthz K, Gynecol Oncol 1987 27 3 340 349 10.1016/0090-8258(87)90256-3 3040545 (Pubitemid 17158006)
39. Detection of human papillomavirus DNA and genotyping in patients with epithelial ovarian carcinoma. Atalay F, Taskiran C, Taner MZ, Pak I, Or M, Tuncer S, J Obstet Gynaecol Res 2007 33 6 823 828 10.1111/j.1447-0756.2007. 00663.x 18001449 (Pubitemid 350086515)
40. Role of human papillomavirus in the development of epithelial ovarian neoplasms in Italian women. Giordano G, D'Adda T, Gnetti L, Froio E, Merisio C, Melpignano M, J Obstet Gynaecol Res 2008 34 2 210 217 10.1111/j.1447-0756.2008. 00759.x 18412784 (Pubitemid 351537736)
41. HPV and p53 expression in epithelial ovarian carcinoma. Kuscu E, Ozdemir BH, Erkanli S, Haberal A, Eur J Gynaecol Oncol 2005 26 6 642 645 16398227 (Pubitemid 43028060)
42. Human papillomavirus and epithelial ovarian neoplasia. Leake JF, Woodruff JD, Searle C, Daniel R, Shah KV, Currie JL, Gynecol Oncol 1989 34 3 268 273 10.1016/0090-8258(89)90158-3 2548934 (Pubitemid 19218563)
43. Analysis of ovarian tumors for the presence of human papillomavirus DNA. Quirk JT, Kupinski JM, DiCioccio RA, J Obstet Gynaecol Res 2006 32 2 202 205 10.1111/j.1447-0756.2006.00376.x 16594925
44. Chimeric human papillomavirus type 16 (HPV-16) L1 particles presenting the common neutralizing epitope for the L2 minor capsid protein of HPV-6 and HPV-16. Varsani A, Williamson AL, de Villiers D, Becker I, Christensen ND, Rybicki EP, J Virol 2003 77 15 8386 8393 10.1128/JVI.77.15.8386-8393.2003 12857908 (Pubitemid 36871467)
45. Improved amplification of genital human papillomaviruses. Gravitt PE, Peyton CL, Alessi TQ, Wheeler CM, Coutlee F, Hildesheim A, Schiffman MH, Scott DR, Apple RJ, J Clin Microbiol 2000 38 1 357 361 10618116 (Pubitemid 30043317)
46. Human papillomavirus testing methods. Hubbard RA, Arch Pathol Lab Med 2003 127 8 940 945 12873165 (Pubitemid 36994852)
47. Type-specific detection of human papillomaviruses in a routine laboratory setting-improved sensitivity and specificity of PCR and sequence analysis compared to direct hybridisation. Kosel S, Burggraf S, Mommsen J, Engelhardt W, Olgemoller B, Clin Chem Lab Med 2003 41 6 787 791 12880142 (Pubitemid 36834123)
48. Prevalence of HPV genotypes determined by PCR and DNA sequencing in cervical specimens from French women with or without abnormalities. Pannier-Stockman C, Segard C, Bennamar S, Gondry J, Boulanger JC, Sevestre H, Castelain S, Duverlie G, J Clin Virol 2008 42 4 353 360 10.1016/j.jcv.2008.03. 022 18485810
49. Human papillomavirus in benign and malignant ovarian and endometrial tissues. Lai CH, Hsueh S, Lin CY, Huang MY, You GB, Chang HC, Pao CC, Int J Gynecol Pathol 1992 11 3 210 215 10.1097/00004347-199207000-00007 1328079
50. Detection of human papillomavirus in surface epithelial ovarian carcinoma using in situ hybridization technique. Sana'a MH Alizi FAM, Abdul-Majeed BA, Fac Med Baghdad 2012 54 1 54 62
51. Endometrial mucinous microglandular adenocarcinoma: morphologic, immunohistochemical features, and emphasis in the human papillomavirus status. Giordano G, D'Adda T, Gnetti L, Merisio C, Melpignano M, Int J Gynecol Pathol 2006 25 1 77 82 10.1097/01.pgp.0000177126.15314.bd 16306789 (Pubitemid 44638340)
52. Infection of human papillomaviruses in cancers of different human organ sites. Shukla S, Bharti AC, Mahata S, et al. Indian J Med Res 2009 130 3 222 233 19901431
53. Metastatic endocervical adenocarcinoma presenting as a virilizing ovarian mass during pregnancy. Powell JL, Bock KA, Gentry JK, White WC, Ronnett BM, Obstet Gynecol 2002 100 5 Pt 2 1129 1133 12423833 (Pubitemid 35341379)
54. Utility of HPV analysis for evaluation of possible metastatic disease in women with cervical cancer. Plaza JA, Ramirez NC, Nuovo GJ, Int J Gynecol Pathol 2004 23 1 7 12 10.1097/01.pgp.0000101084.35393.03 14668543 (Pubitemid 38018230)
55. Variation of human papillomavirus type 6 (HPV-6) and HPV-11 genomes sampled throughout the world. Heinzel PA, Chan SY, Ho L, O'Connor M, Balaram P, Campo MS, Fujinaga K, Kiviat N, Kuypers J, Pfister H, et al. J Clin Microbiol 1995 33 7 1746 1754 7665641
56. Human papillomavirus infection: biology, epidemiology, and prevention. Scheurer ME, Tortolero-Luna G, Adler-Storthz K, Int J Gynecol Cancer 2005 15 5 727 746 10.1111/j.1525-1438.2005.00246.x 16174218 (Pubitemid 41783075)
57. Detection and genotyping of human papillomaviruses and their role in the development of ovarian carcinomas. Malisic E, Jankovic R, Jakovljevic K, Arch Gynecol Obstet 2012 286 3 723 728 10.1007/s00404-012-2367-6 22569714
58. Correlation of modified human papilloma virus early gene expression with altered growth properties in C4-1 cervical carcinoma cells. von Knebel DM, Oltersdorf T, Schwarz E, Gissmann L, Cancer Res 1988 48 13 3780 3786 2837324
59. Reversible repression of papillomavirus oncogene expression in cervical carcinoma cells: consequences for the phenotype and E6-p53 and E7-pRB interactions. von Knebel DM, Rittmuller C, Aengeneyndt F, Jansen-Durr P, Spitkovsky D, J Virol 1994 68 5 2811 2821 8151752 (Pubitemid 24129728)
60. Influence of chromosomal integration on glucocorticoid-regulated transcription of growth-stimulating papillomavirus genes E6 and E7 in cervical carcinoma cells. von Knebel Doeberitz M, Bauknecht T, Bartsch D, Zur Hausen H, Proc Natl Acad Sci U S A 1991 88 4 1411 1415 10.1073/pnas.88.4.1411 1847520 (Pubitemid 21916234)
61. Analysis of the physical state of different human papillomavirus DNAs in intraepithelial and invasive cervical neoplasm. Cullen AP, Reid R, Campion M, Lorincz AT, J Virol 1991 65 2 606 612 1846186
62. HPV16 and HPV18 genotyping in cervical cancer screening. Ronco G, Franceschi S, Segnan N, Lancet Oncol 2011 12 9 831 832 10.1016/S1470-2045(11) 70195-4 21865085
63. The relationship between HPV16 and HPV18 viral load and cervical lesions progression. Botezatu A, Socolov D, Goia CD, Iancu IV, Ungureanu C, Huica I, Anton G, Roum Arch Microbiol Immunol 2009 68 3 175 182 20361539
64. Detection of high-risk cervical intraepithelial neoplasia and cervical cancer by amplification of transcripts derived from integrated papillomavirus oncogenes. Klaes R, Woerner SM, Ridder R, Wentzensen N, Duerst M, Schneider A, Lotz B, Melsheimer P, von Knebel DM, Cancer Res 1999 59 24 6132 6136 10626803 (Pubitemid 30035633)
65. Human papillomavirus type 16 integration in cervical carcinoma in situ and in invasive cervical cancer. Arias-Pulido H, Peyton CL, Joste NE, Vargas H, Wheeler CM, J Clin Microbiol 2006 44 5 1755 1762 10.1128/JCM.44.5.1755-1762.2006 16672403 (Pubitemid 43726265)
66. PCR detection of human papillomavirus: comparison between MY09/MY11 and GP5+/GP6+ primer systems. Qu W, Jiang G, Cruz Y, Chang CJ, Ho GY, Klein RS, Burk RD, J Clin Microbiol 1997 35 6 1304 1310 9163434 (Pubitemid 27216785)
67. Detection and typing of human papillomavirus by e6 nested multiplex PCR. Sotlar K, Diemer D, Dethleffs A, Hack Y, Stubner A, Vollmer N, Menton S, Menton M, Dietz K, Wallwiener D, et al. J Clin Microbiol 2004 42 7 3176 3184 10.1128/JCM.42.7.3176-3184.2004 15243079 (Pubitemid 38938077)